{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T03:41:14Z","timestamp":1774928474532,"version":"3.50.1"},"reference-count":107,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhltonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Heart and Lung Transplantation"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.healun.2016.03.018","type":"journal-article","created":{"date-parts":[[2016,4,2]],"date-time":"2016-04-02T11:57:24Z","timestamp":1459598244000},"page":"550-559","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["The potential role of microRNAs in lung allograft rejection"],"prefix":"10.1016","volume":"35","author":[{"given":"Shameem S.","family":"Ladak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6954-9611","authenticated-orcid":false,"given":"Chris","family":"Ward","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simi","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.healun.2016.03.018_bib1","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1136\/thx.24.4.383","article-title":"Transplantation of the heart and both lungs I. Historical review","volume":"24","author":"Cooper","year":"1969","journal-title":"Thorax"},{"key":"10.1016\/j.healun.2016.03.018_bib2","series-title":"Clinical organ transplantation","author":"Calne","year":"1971"},{"key":"10.1016\/j.healun.2016.03.018_bib3","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1513\/pats.200807-072GO","article-title":"General overview of lung transplantation and review of organ allocation","volume":"6","author":"Orens","year":"2009","journal-title":"Proc Am Thorac Soc"},{"key":"10.1016\/j.healun.2016.03.018_bib4","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1177\/1753465808093514","article-title":"Update on lung transplantation","volume":"2","author":"Gottlieb","year":"2008","journal-title":"Ther Adv Respir Dis"},{"key":"10.1016\/j.healun.2016.03.018_bib5","first-page":"107","article-title":"Lung transplantation: a treatment option in end-stage lung disease","volume":"111","author":"Hartert","year":"2014","journal-title":"Dtsch Arztebl Int"},{"key":"10.1016\/j.healun.2016.03.018_bib6","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/tri.12341","article-title":"Mechanistic differences between phenotypes of chronic lung allograft dysfunction after lung transplantation","volume":"27","author":"Suwara","year":"2014","journal-title":"Transpl Int"},{"key":"10.1016\/j.healun.2016.03.018_bib7","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/1749-8090-6-92","article-title":"A review of bronchiolitis obliterans syndrome and therapeutic strategies","volume":"6","author":"Hayes","year":"2011","journal-title":"J Cardiothorac Surg"},{"key":"10.1016\/j.healun.2016.03.018_bib8","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1164\/ajrccm.152.4.7551389","article-title":"Treatment of presumed and proven acute rejection following six months of lung transplant survival","volume":"152","author":"Kesten","year":"1991","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.healun.2016.03.018_bib9","doi-asserted-by":"crossref","first-page":"40","DOI":"10.2174\/157339808783497774","article-title":"New insights into acute and chronic lung rejection","volume":"4","author":"Neuringer","year":"2008","journal-title":"Curr Respir Med Rev"},{"key":"10.1016\/j.healun.2016.03.018_bib10","doi-asserted-by":"crossref","first-page":"246","DOI":"10.4037\/ajcc2008.17.3.246","article-title":"Course of illness after the onset of chronic rejection in lung transplant recipients","volume":"17","author":"Song","year":"2008","journal-title":"Am J Crit Care"},{"key":"10.1016\/j.healun.2016.03.018_bib11","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.bbmt.2013.03.017","article-title":"Lung histology predicts outcome of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation","volume":"19","author":"Holbro","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.healun.2016.03.018_bib12","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1016\/j.athoracsur.2011.01.076","article-title":"Predictors of acute rejection after lung transplantation","volume":"91","author":"Mangi","year":"2011","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.healun.2016.03.018_bib13","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S0022-5223(05)80003-0","article-title":"Obliterative bronchiolitis after lung and heart-lung transplantation. An analysis of risk factors and management","volume":"110","author":"Bando","year":"1995","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.healun.2016.03.018_bib14","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1513\/pats.200601-007AW","article-title":"Mechanisms of airway obliteration after lung transplantation","volume":"3","author":"Nicod","year":"2006","journal-title":"Proc Am Thorac Soc"},{"key":"10.1016\/j.healun.2016.03.018_bib15","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1136\/thx.2005.043026","article-title":"Phenotype of airway epithelial cells suggests epithelial to mesenchymal cell transition in clinically stable lung transplant recipients","volume":"60","author":"Ward","year":"2005","journal-title":"Thorax"},{"key":"10.1016\/j.healun.2016.03.018_bib16","doi-asserted-by":"crossref","first-page":"e92287","DOI":"10.1371\/journal.pone.0092287","article-title":"Remodeling of aorta extracellular matrix as a result of transient high oxygen exposure in newborn rats: implication for arterial rigidity and hypertension risk","volume":"9","author":"Huyard","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.healun.2016.03.018_bib17","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/j.1440-1843.2012.02173.x","article-title":"Emerging evidence of epithelial-to-mesenchymal transition in lung carcinogenesis","volume":"17","author":"Sato","year":"2012","journal-title":"Respirology"},{"key":"10.1016\/j.healun.2016.03.018_bib18","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/1471-2466-14-64","article-title":"Pulmonary delivery of docosahexaenoic acid mitigates bleomycin-induced pulmonary fibrosis","volume":"14","author":"Zhao","year":"2014","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.healun.2016.03.018_bib19","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1152\/physrev.00022.2006","article-title":"Matrix metalloproteinases in lung: multiple, multifarious, and multifaceted","volume":"87","author":"Greenlee","year":"2007","journal-title":"Physiol Rev"},{"key":"10.1016\/j.healun.2016.03.018_bib20","doi-asserted-by":"crossref","first-page":"L1064","DOI":"10.1152\/ajplung.00027.2014","article-title":"Lung volume quantified by MRI reflects extracellular-matrix deposition and altered pulmonary function in bleomycin models of fibrosis: effects of SOM230","volume":"306","author":"Egger","year":"2014","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.healun.2016.03.018_bib21","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1161\/01.CIR.0000085658.98621.49","article-title":"Ventricular remodeling after infarction and the extracellular collagen matrix: when is enough enough?","volume":"108","author":"Jugdutt","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2016.03.018_bib22","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1755-1536-3-2","article-title":"Epithelial-mesenchymal transition in primary human bronchial epithelial cells is Smad-dependent and enhanced by fibronectin and TNF-alpha","volume":"3","author":"Camara","year":"2010","journal-title":"Fibrogen Tissue Repair"},{"key":"10.1016\/j.healun.2016.03.018_bib23","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/cvr\/cvu062","article-title":"Crosstalk between fibroblasts and inflammatory cells","volume":"102","author":"Van Linthout","year":"2014","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.healun.2016.03.018_bib24","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1101\/gad.14.2.163","article-title":"Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis","volume":"14","author":"Yu","year":"2000","journal-title":"Genes Dev"},{"key":"10.1016\/j.healun.2016.03.018_bib25","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1183\/09031936.00077309","article-title":"Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology","volume":"35","author":"Vancheri","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1016\/j.healun.2016.03.018_bib26","doi-asserted-by":"crossref","unstructured":"Willis BC, Borok Z. TGF-\u03b2-induced EMT: mechanisms and implications for fibrotic lung disease. Am J Physiol Lung Cell Mol Physiol. 2007;293:L525-34.","DOI":"10.1152\/ajplung.00163.2007"},{"key":"10.1016\/j.healun.2016.03.018_bib27","unstructured":"Ladak SS, Ali S, Ward C. The potential role of miRNA-200b in the development of Bronchiolitis obliterans syndrome. In Immunology (Vol. 143, pp. 171-171), New Jersey, Wiley-Blackwell; 2014."},{"key":"10.1016\/j.healun.2016.03.018_bib28","doi-asserted-by":"crossref","first-page":"e145","DOI":"10.1016\/j.ddmod.2012.11.003","article-title":"Micromanaging microRNAs: using murine models to study microRNAs in lung fibrosis","volume":"10","author":"Lino","year":"2013","journal-title":"Drug Discov Today Dis Mod"},{"key":"10.1016\/j.healun.2016.03.018_bib29","doi-asserted-by":"crossref","first-page":"572","DOI":"10.2174\/156800909788486731","article-title":"Potential uses of microRNA in lung cancer diagnosis, prognosis, and therapy","volume":"9","author":"Wang","year":"2009","journal-title":"Curr Cancer Drug Targets"},{"key":"10.1016\/j.healun.2016.03.018_bib30","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nrg3198","article-title":"MicroRNA profiling: approaches and considerations","volume":"13","author":"Pritchard","year":"2012","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.healun.2016.03.018_bib31","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3389\/fphys.2013.00223","article-title":"Developing microRNA screening as a functional genomics tool for disease research","volume":"4","author":"Lemons","year":"2013","journal-title":"Front Physiol"},{"key":"10.1016\/j.healun.2016.03.018_bib32","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0092-8674(03)01018-3","article-title":"Prediction of mammalian microRNA targets","volume":"115","author":"Lewis","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.healun.2016.03.018_bib33","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1186\/gb-2003-5-1-r1","article-title":"MicroRNA targets in Drosophila","volume":"5","author":"Enright","year":"2003","journal-title":"Genome Biol"},{"key":"10.1016\/j.healun.2016.03.018_bib34","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/ng1536","article-title":"Combinatorial microRNA target predictions","volume":"37","author":"Krek","year":"2005","journal-title":"Nat Genet"},{"key":"10.1016\/j.healun.2016.03.018_bib35","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1101\/gad.1745709","article-title":"Coherent but overlapping expression of microRNAs and their targets during vertebrate development","volume":"23","author":"Shkumatava","year":"2009","journal-title":"Genes Dev"},{"key":"10.1016\/j.healun.2016.03.018_bib36","doi-asserted-by":"crossref","first-page":"6845","DOI":"10.1093\/nar\/gkr330","article-title":"Experimental strategies for microRNA target identification","volume":"39","author":"Thomson","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.healun.2016.03.018_bib37","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/978-1-4939-1568-2_18","article-title":"MicroRNA function in mast cell biology: protocols to characterize and modulate microRNA expression","volume":"1220","author":"Maltby","year":"2015","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.healun.2016.03.018_bib38","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ymeth.2007.09.005","article-title":"Experimental validation of miRNA targets","volume":"44","author":"Kuhn","year":"2008","journal-title":"Methods"},{"key":"10.1016\/j.healun.2016.03.018_bib39","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.1096\/fj.11-199240","article-title":"miR-146a regulates mechanotransduction and pressure-induced inflammation in small airway epithelium","volume":"26","author":"Huang","year":"2012","journal-title":"FASEB J"},{"key":"10.1016\/j.healun.2016.03.018_bib40","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.trsl.2011.02.001","article-title":"MicroRNAs: miRRORS of health and disease","volume":"157","author":"Montano","year":"2011","journal-title":"Transl Res"},{"key":"10.1016\/j.healun.2016.03.018_bib41","doi-asserted-by":"crossref","DOI":"10.1186\/2213-0802-1-12","article-title":"MicroRNAs implicated in dysregulation of gene expression following human lung transplantation","volume":"1","author":"Zhang","year":"2013","journal-title":"Transl Respir Med"},{"key":"10.1016\/j.healun.2016.03.018_bib42","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/1471-2164-8-166","article-title":"Characterization of microRNA expression profiles in normal human tissues","volume":"8","author":"Liang","year":"2007","journal-title":"BMC Genomics"},{"key":"10.1016\/j.healun.2016.03.018_bib43","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3389\/fimmu.2014.00413","article-title":"Extracellular vesicle profiling and their use as potential disease specific biomarker","volume":"5","author":"Julich","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.healun.2016.03.018_bib44","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.humimm.2015.07.021","article-title":"OR15 De novo development of DSA following human lung transplantation is associated with changes on circulating micro-RNA involved in T and B cell regulation and fibrogenesis","volume":"76","author":"Xu","year":"2015","journal-title":"Hum Immunol"},{"key":"10.1016\/j.healun.2016.03.018_bib45","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1111\/ajt.13185","article-title":"Dysregulated MicroRNA expression and chronic lung allograft rejection in recipients with antibodies to donor HLA","volume":"15","author":"Xu","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2016.03.018_bib46","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.healun.2015.03.021","article-title":"MicroRNA-144 dysregulates the transforming growth factor-beta signaling cascade and contributes to the development of bronchiolitis obliterans syndrome after human lung transplantation","volume":"34","author":"Xu","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2016.03.018_bib47","doi-asserted-by":"crossref","first-page":"14131","DOI":"10.1038\/srep14131","article-title":"The anti-fibrotic effects and mechanisms of microRNA-486-5p in pulmonary fibrosis","volume":"5","author":"Ji","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.healun.2016.03.018_bib48","first-page":"7050","article-title":"Integrated analysis of transcription factor, microRNA and LncRNA in an animal model of obliterative bronchiolitis","volume":"8","author":"Dong","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.healun.2016.03.018_bib49","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.ajpath.2013.06.032","article-title":"miR-21-containing microvesicles from injured tubular epithelial cells promote tubular phenotype transition by targeting PTEN protein","volume":"183","author":"Zhou","year":"2013","journal-title":"Am J Pathol"},{"key":"10.1016\/j.healun.2016.03.018_bib50","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.trim.2013.08.005","article-title":"Differential expression and functions of microRNAs in liver transplantation and potential use as non-invasive biomarkers","volume":"29","author":"Wei","year":"2013","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.healun.2016.03.018_bib51","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.molonc.2012.04.001","article-title":"Identification of recurrence-related microRNAs in hepatocellular carcinoma following liver transplantation","volume":"6","author":"Han","year":"2012","journal-title":"Mol Oncol"},{"key":"10.1016\/j.healun.2016.03.018_bib52","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/bjc.2014.621","article-title":"Identification of a bona fide microRNA biomarker in serum exosomes that predicts hepatocellular carcinoma recurrence after liver transplantation","volume":"112","author":"Sugimachi","year":"2015","journal-title":"Br J Cancer"},{"key":"10.1016\/j.healun.2016.03.018_bib53","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/j.1600-6143.2010.03032.x","article-title":"MicroRNAs as immune regulators: implications for transplantation","volume":"10","author":"Harris","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2016.03.018_bib54","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1111\/j.1600-6143.2011.03679.x","article-title":"Urinary miR-210 as a mediator of acute T-cell mediated rejection in renal allograft recipients","volume":"11","author":"Lorenzen","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2016.03.018_bib55","doi-asserted-by":"crossref","first-page":"5330","DOI":"10.1073\/pnas.0813121106","article-title":"MicroRNA expression profiles predictive of human renal allograft status","volume":"106","author":"Anglicheau","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.healun.2016.03.018_bib56","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/1749-8090-8-165","article-title":"Circulating miRNAs reflect early myocardial injury and recovery after heart transplantation","volume":"8","author":"Wang","year":"2013","journal-title":"J Cardiothorac Surg"},{"key":"10.1016\/j.healun.2016.03.018_bib57","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/ajt.13421","article-title":"RNA Profiling in human and murine transplanted hearts: identification and validation of therapeutic targets for acute cardiac and renal allograft rejection","volume":"16","author":"Van Aelst","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2016.03.018_bib58","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.bbrc.2005.05.206","article-title":"Differential expression of components of the microRNA machinery during mouse organogenesis","volume":"334","author":"Lu","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.healun.2016.03.018_bib59","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/978-94-007-5590-1_7","article-title":"MicroRNAs in the lung","volume":"774","author":"Sittka","year":"2013","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.healun.2016.03.018_bib60","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1101\/gr.082701.108","article-title":"Most mammalian mRNAs are conserved targets of microRNAs","volume":"19","author":"Friedman","year":"2009","journal-title":"Genome Res"},{"key":"10.1016\/j.healun.2016.03.018_bib61","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1371\/journal.pcbi.0010013","article-title":"microRNA target predictions across seven Drosophila species and comparison to mammalian targets","volume":"1","author":"Grun","year":"2005","journal-title":"PLoS Comput Biol"},{"key":"10.1016\/j.healun.2016.03.018_bib62","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1073\/pnas.0510839103","article-title":"Dicer function is essential for lung epithelium morphogenesis","volume":"103","author":"Harris","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.healun.2016.03.018_bib63","doi-asserted-by":"crossref","first-page":"15805","DOI":"10.1073\/pnas.0707628104","article-title":"MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B","volume":"104","author":"Fabbri","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.healun.2016.03.018_bib64","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ydbio.2009.06.020","article-title":"miR-17 family of microRNAs controls FGF10-mediated embryonic lung epithelial branching morphogenesis through MAPK14 and STAT3 regulation of E-cadherin distribution","volume":"333","author":"Carraro","year":"2009","journal-title":"Dev Biol"},{"key":"10.1016\/j.healun.2016.03.018_bib65","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1126\/science.1139253","article-title":"Requirement of bic\/microRNA-155 for normal immune function","volume":"316","author":"Rodriguez","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.healun.2016.03.018_bib66","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.semcancer.2008.01.005","article-title":"MicroRNAs and immunity: novel players in the regulation of normal immune function and inflammation","volume":"18","author":"Sonkoly","year":"2008","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.healun.2016.03.018_bib67","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1378\/chest.130.3.847","article-title":"Sequential gene expression profiling in lung transplant recipients with chronic rejection","volume":"130","author":"Lu","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.healun.2016.03.018_bib68","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1471-2466-13-63","article-title":"Altered microRNA expression profile during epithelial wound repair in bronchial epithelial cells","volume":"13","author":"Szczepankiewicz","year":"2013","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.healun.2016.03.018_bib69","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3389\/fgene.2012.00120","article-title":"miR-34\u2014a microRNA replacement therapy is headed to the clinic","volume":"3","author":"Bader","year":"2012","journal-title":"Front Gene"},{"key":"10.1016\/j.healun.2016.03.018_bib70","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1038\/labinvest.2010.113","article-title":"Difference in expression of hepatic microRNAs miR-29c, miR-34a, miR-155, and miR-200b is associated with strain-specific susceptibility to dietary nonalcoholic steatohepatitis in mice","volume":"90","author":"Pogribny","year":"2010","journal-title":"Lab Invest"},{"key":"10.1016\/j.healun.2016.03.018_bib71","doi-asserted-by":"crossref","first-page":"5689","DOI":"10.4049\/jimmunol.180.8.5689","article-title":"Rapid changes in microRNA-146a expression negatively regulate the IL-1beta-induced inflammatory response in human lung alveolar epithelial cells","volume":"180","author":"Perry","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.healun.2016.03.018_bib72","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.1096\/fj.11-199240","article-title":"miR-146a regulates mechanotransduction and pressure-induced inflammation in small airway epithelium","volume":"26","author":"Huang","year":"2012","journal-title":"FASEB J"},{"key":"10.1016\/j.healun.2016.03.018_bib73","doi-asserted-by":"crossref","first-page":"e60317","DOI":"10.1371\/journal.pone.0060317","article-title":"miR-146a inhibits cell growth, cell migration and induces apoptosis in non-small cell lung cancer cells","volume":"8","author":"Chen","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.healun.2016.03.018_bib74","doi-asserted-by":"crossref","first-page":"130","DOI":"10.2174\/1874312901206010130","article-title":"Role of MicroRNAs in fibrosis","volume":"6","author":"Vettori","year":"2010","journal-title":"Open Rheumatol J"},{"key":"10.1016\/j.healun.2016.03.018_bib75","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1084\/jem.20100035","article-title":"miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis","volume":"207","author":"Liu","year":"2010","journal-title":"J Exp Med"},{"key":"10.1016\/j.healun.2016.03.018_bib76","doi-asserted-by":"crossref","first-page":"A68","DOI":"10.1136\/thoraxjnl-2015-207770.125","article-title":"MicroRNA-200B represses TGF-beta 1 induced EMT in BEAS-2B and primary bronchial epithelial cells","volume":"70","author":"Ladak","year":"2015","journal-title":"Thorax"},{"key":"10.1016\/j.healun.2016.03.018_bib77","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1672-0229(08)60044-3","article-title":"A brief review on the mechanisms of miRNA regulation","volume":"7","author":"Cai","year":"2009","journal-title":"Genom Proteom Bioinform"},{"key":"10.1016\/j.healun.2016.03.018_bib78","doi-asserted-by":"crossref","first-page":"259131","DOI":"10.1155\/2014\/259131","article-title":"Novel insights into miRNA in lung and heart inflammatory diseases","volume":"2014","author":"Kishore","year":"2014","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.healun.2016.03.018_bib79","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s10555-012-9368-6","article-title":"MicroRNA control of epithelial-mesenchymal transition and metastasis","volume":"31","author":"Zhang","year":"2012","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.healun.2016.03.018_bib80","doi-asserted-by":"crossref","first-page":"7027","DOI":"10.1158\/0008-5472.CAN-10-2010","article-title":"The promise of microRNA replacement therapy","volume":"70","author":"Bader","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.healun.2016.03.018_bib81","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.15252\/emmm.201303604","article-title":"MicroRNA mimicry blocks pulmonary fibrosis","volume":"6","author":"Montgomery","year":"2014","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.healun.2016.03.018_bib82","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3747\/co.v17i1.356","article-title":"MicroRNA let-7: an emerging next-generation cancer therapeutic","volume":"17","author":"Barh","year":"2010","journal-title":"Curr Oncol"},{"key":"10.1016\/j.healun.2016.03.018_bib83","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1126\/science.1113329","article-title":"Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA","volume":"309","author":"Jopling","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.healun.2016.03.018_bib84","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1126\/science.1178178","article-title":"Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection","volume":"327","author":"Lanford","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.healun.2016.03.018_bib85","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1126\/science.1139089","article-title":"Control of stress-dependent cardiac growth and gene expression by a microRNA","volume":"316","author":"van Rooij","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.healun.2016.03.018_bib86","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1134\/S0006297914060078","article-title":"HMGA1 is a new target of miR-195 involving isoprenaline-induced cardiomyocyte hypertrophy","volume":"79","author":"You","year":"2014","journal-title":"Biochemistry (Mosc)"},{"key":"10.1016\/j.healun.2016.03.018_bib87","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-6143.2012.04313.x","article-title":"MicroRNAs as biomarkers in solid organ transplantation","volume":"13","author":"Mas","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2016.03.018_bib88","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1097\/TP.0b013e3181efcfbc","article-title":"Animal models of chronic allograft injury: contributions and limitations to understanding the mechanism of long-term graft dysfunction","volume":"90","author":"Bedi","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2016.03.018_bib89","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/nrd3179","article-title":"Targeting microRNAs in cancer: rationale, strategies and challenges","volume":"9","author":"Garzon","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.healun.2016.03.018_bib90","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/nrd4359","article-title":"Therapeutic targeting of microRNAs: current status and future challenges","volume":"13","author":"Li","year":"2014","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.healun.2016.03.018_bib91","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.2217\/nnm.14.162","article-title":"Strategies to antagonize miRNA functions in vitro and in vivo","volume":"9","author":"Baigude","year":"2014","journal-title":"Nanomedicine (Lond)"},{"key":"10.1016\/j.healun.2016.03.018_bib92","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3389\/fgene.2012.00056","article-title":"Exosomal miRNAs: biological properties and therapeutic potential","volume":"3","author":"Hu","year":"2012","journal-title":"Front Genet"},{"key":"10.1016\/j.healun.2016.03.018_bib93","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/toxsci\/kfs210","article-title":"Expression, circulation, and excretion profile of microRNA-21, -155, and -18a following acute kidney injury","volume":"129","author":"Saikumar","year":"2012","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.healun.2016.03.018_bib94","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1093\/eurheartj\/ehu346","article-title":"MicroRNAs as non-invasive biomarkers of heart transplant rejection","volume":"35","author":"Van Huyen","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.healun.2016.03.018_bib95","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/1749-8090-8-165","article-title":"Circulating miRNAs reflect early myocardial injury and recovery after heart transplantation","volume":"8","author":"Wang","year":"2013","journal-title":"J Cardiothorac Surg"},{"key":"10.1016\/j.healun.2016.03.018_bib96","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/lt.22438","article-title":"Hepatocyte-derived microRNAs as serum biomarkers of hepatic injury and rejection after liver transplantation","volume":"18","author":"Farid","year":"2012","journal-title":"Liver Transpl"},{"key":"10.1016\/j.healun.2016.03.018_bib97","doi-asserted-by":"crossref","first-page":"259131","DOI":"10.1155\/2014\/259131","article-title":"Novel insights into miRNA in lung and heart inflammatory diseases","volume":"2014","author":"Kishore","year":"2014","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.healun.2016.03.018_bib98","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1755-8794-7-46","article-title":"MicroRNA and mRNA expression profiling in rat acute respiratory distress syndrome","volume":"7","author":"Huang","year":"2014","journal-title":"BMC Med Genomics"},{"key":"10.1016\/j.healun.2016.03.018_bib99","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1093\/ndt\/gfr485","article-title":"Circulating microRNA expression is reduced in chronic kidney disease","volume":"26","author":"Neal","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.healun.2016.03.018_bib100","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.2215\/CJN.00520109","article-title":"MicroRNAs and their role in progressive kidney diseases","volume":"4","author":"Kato","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.healun.2016.03.018_bib101","doi-asserted-by":"crossref","DOI":"10.1093\/ndt\/gfv191.19","article-title":"SP299MICRORNA-200B as predictive biomarker of chronic kidney disease (CKD) in patients undergoing radical nephrectomy","author":"Trevisani","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.healun.2016.03.018_bib102","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/eurjhf\/hfr155","article-title":"Serum levels of microRNAs in patients with heart failure","volume":"14","author":"Goren","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.healun.2016.03.018_bib103","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1248\/bpb.b12-00578","article-title":"MicroRNA 210 as a biomarker for congestive heart failure","volume":"36","author":"Endo","year":"2013","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.healun.2016.03.018_bib104","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/hep.23922","article-title":"Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis","volume":"53","author":"Roderburg","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.healun.2016.03.018_bib105","doi-asserted-by":"crossref","first-page":"e23937","DOI":"10.1371\/journal.pone.0023937","article-title":"Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease","volume":"6","author":"Cermelli","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.healun.2016.03.018_bib106","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.arbres.2012.04.011","article-title":"Role of MicroRNAs in lung disease","volume":"48","author":"Angulo","year":"2012","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.healun.2016.03.018_bib107","doi-asserted-by":"crossref","first-page":"e1238","DOI":"10.1038\/cddis.2014.207","article-title":"Integrated analyses identify the involvement of microRNA-26a in epithelial-mesenchymal transition during idiopathic pulmonary fibrosis","volume":"5","author":"Liang","year":"2014","journal-title":"Cell Death Dis"}],"container-title":["The Journal of Heart and Lung Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249816300717?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249816300717?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T08:32:13Z","timestamp":1760949133000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053249816300717"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":107,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S1053249816300717"],"URL":"https:\/\/doi.org\/10.1016\/j.healun.2016.03.018","relation":{},"ISSN":["1053-2498"],"issn-type":[{"value":"1053-2498","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The potential role of microRNAs in lung allograft rejection","name":"articletitle","label":"Article Title"},{"value":"The Journal of Heart and Lung Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.healun.2016.03.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 International Society for Heart and Lung Transplantation. All rights reserved.","name":"copyright","label":"Copyright"}]}}